Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-31
DOI
10.1038/s41598-017-15030-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Balancing Between Aging and Cancer: Molecular Genetics Meets Traditional Chinese Medicine
- (2017) Jing Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Chemical Profiling Combined with “Omics” Technologies (CP-Omics): a Strategy to Understand the Compatibility Mechanisms and Simplify Herb Formulas in Traditional Chinese Medicines
- (2017) Tengfei Xu et al. PHYTOCHEMICAL ANALYSIS
- Tea phytochemicals for breast cancer prevention and intervention: From bench to bedside and beyond
- (2017) Dona Sinha et al. SEMINARS IN CANCER BIOLOGY
- Network Analysis Reveals A Signaling Regulatory Loop in the PIK3CA -mutated Breast Cancer Predicting Survival Outcome
- (2017) Shauna R. McGee et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Preventive and Risk Reduction Strategies for Women at High Risk of Developing Breast Cancer: a Review
- (2016) Arvind Krishnamurthy et al. Asian Pacific Journal of Cancer Prevention
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The selective estrogen receptor modulators in breast cancer prevention
- (2016) Fangxuan Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of the physical microenvironment on tumor progression and metastasis
- (2016) Fabian Spill et al. CURRENT OPINION IN BIOTECHNOLOGY
- Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation
- (2016) Tomonori Yaguchi et al. INTERNATIONAL IMMUNOLOGY
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer
- (2016) Makito Miyake et al. NEOPLASIA
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs
- (2015) Lin Tao et al. PHARMACOLOGICAL RESEARCH
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation
- (2015) Neng Wang et al. Oncotarget
- Breast Cancer Prevention
- (2014) David M. Euhus et al. Breast Journal
- Network Pharmacology: A New Approach for Chinese Herbal Medicine Research
- (2013) Gui-biao Zhang et al. Evidence-based Complementary and Alternative Medicine
- Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice
- (2013) Hui Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Signaling Network Assessment of Mutations and Copy Number Variations Predict Breast Cancer Subtype-Specific Drug Targets
- (2013) Naif Zaman et al. Cell Reports
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Chemopreventive efficacy of Phyllanthus emblica L. (amla) fruit extract on 7,12-dimethylbenz(a)anthracene induced oral carcinogenesis – A dose–response study
- (2012) Mani Krishnaveni et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer
- (2012) Jessica P. Gopie et al. Familial Cancer
- Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer
- (2011) W.-L. Cheng et al. ANNALS OF ONCOLOGY
- Use of Chinese medicine by women with breast cancer: A nationwide cross-sectional study in Taiwan
- (2011) Yi-Hsien Lin et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Exemestane for Breast-Cancer Prevention in Postmenopausal Women
- (2011) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developments in cancer prevention and treatment using traditional Chinese medicine
- (2011) Hongsheng Lin et al. Frontiers of Medicine
- Association of Risk-Reducing Surgery With Cancer Risks and Mortality in BRCA Mutation Carriers
- (2010) Bernadette A. M. Heemskerk-Gerritsen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Signaling network analysis of ubiquitin-mediated proteins suggests correlations between the 26S proteasome and tumor progression
- (2009) Cong Fu et al. Molecular BioSystems
- Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer
- (2008) H. Kawanishi et al. CLINICAL CANCER RESEARCH
- IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole
- (2008) Jack Cuzick Expert Review of Anticancer Therapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started